So sánh phương pháp

	Bảng câu hỏi về sự hài lòng với điều trị thuốc (TSQM)	Thang đo Đánh giá Mức độ Tuân thủ Điều trị bằng Thuốc (MARS)
Lĩnh vực	Dược lý học	Dược lý học
Họ	Process / pipeline	Process / pipeline
Năm ra đời	2004	2000
Người khởi xướng	Mary Jo Atkinson and colleagues	Kathryn Thompson, Jayashri Kulkarni, and Anthony A. Sergejew
Loại	Self-report	Self-report
Công trình gốc	Atkinson, M. J., Sinha, A., Hass, S. L., Colman, S. S., Kumar, R. N., Berman, B. M., & Wolpert, B. (2004). Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel of chronically ill individuals. Health and Quality of Life Outcomes, 2(1), 12.	Thompson, K., Kulkarni, J., & Sergejew, A. A. (2000). Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research, 42(3), 241-247.
Tên gọi khác	TSQM	MARS
Liên quan	4	4
Tóm tắt	The Treatment Satisfaction Questionnaire for Medication (TSQM) is a 14-item generic measure developed by Atkinson and colleagues in 2004 to assess patient satisfaction with medication across diverse therapeutic areas and disease conditions. It measures four key dimensions—Effectiveness, Side Effects, Convenience, and Global Satisfaction—with standardized 0–100 scoring, making it suitable for cross-disease comparison and health economic evaluation. The TSQM has become a standard outcome in pharmaceutical research, clinical trials, and real-world medication effectiveness studies.	The Medication Adherence Rating Scale (MARS) is a 10-item self-report measure developed by Thompson, Kulkarni, and Sergejew in 2000 to assess medication adherence behaviors and attitudes in psychiatric populations, particularly antipsychotic medication use. Although originally validated in schizophrenia, it has been successfully applied across diverse medical conditions including hypertension, diabetes, and chronic disease management, providing a quick, sensitive assessment of actual adherence frequency and admission of problematic medication-taking behaviors.